Hear Julie Ann Justo, PharmD, MS, FIDSA, BCPS, share her approach to treating CRE infections through a patient case, including a review of the changing epidemiology of CRE, contributing mechanisms of resistance, and current IDSA guidance recommendations based on the latest data.
In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:
Faculty:
Julie Ann Justo, PharmD, MS, FIDSA, BCPS
Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
Link to full program:
https://bit.ly/41a8Mj0
Link to accompanying ClinicalThought commentary:
https://bit.ly/4865T57
Link to downloadable infographic:
https://bit.ly/3t7NpT2